How are patients with rare diseases and their carers in the UK impacted by the way care is coordinated? An exploratory qualitative interview study.

Care coordination Care coordinators Care plans Carer experience Financial impact Multi-disciplinary clinics Patient experience Psychosocial impact Specialist care Undiagnosed conditions

Journal

Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602

Informations de publication

Date de publication:
10 02 2021
Historique:
received: 09 07 2020
accepted: 22 12 2020
entrez: 11 2 2021
pubmed: 12 2 2021
medline: 22 6 2021
Statut: epublish

Résumé

Care coordination is considered important for patients with rare conditions, yet research addressing the impact of care coordination is limited. This study aimed to explore how care coordination (or lack of) impacts on patients and carers. Semi-structured interviews were conducted with 15 patients and carers/parents in the UK, representing a range of rare conditions (including undiagnosed conditions). Transcripts were analysed thematically in an iterative process. Participants described a range of experiences and views in relation to care coordination. Reports of uncoordinated care emerged: appointments were uncoordinated, communication between key stakeholders was ineffective, patients and carers were required to coordinate their own care, and care was not coordinated to meet the changing needs of patients in different scenarios. As a result, participants experienced an additional burden and barriers/delays to accessing care. The impacts described by patients and carers, either attributed to or exacerbated by uncoordinated care, included: impact on physical health (including fatigue), financial impact (including loss of earnings and travel costs), and psychosocial impact (including disruption to school, work and emotional burden). Overall data highlight the importance of flexible care, which meets individual needs throughout patients'/carers' journeys. Specifically, study participants suggested that the impacts may be addressed by: having support from a professional to coordinate care, changing the approach of clinics and appointments (where they take place, which professionals/services are available and how they are scheduled), and improving communication through the use of technology, care plans, accessible points of contact and multi-disciplinary team working. This study provides further evidence of impacts of uncoordinated care; these may be complex and influenced by a number of factors. Approaches to coordination which improve access to care and lessen the time and burden placed on patients and carers may be particularly beneficial. Findings should influence future service developments (and the evaluation of such developments). This will be achieved, in the first instance, by informing the CONCORD Study in the UK.

Sections du résumé

BACKGROUND
Care coordination is considered important for patients with rare conditions, yet research addressing the impact of care coordination is limited. This study aimed to explore how care coordination (or lack of) impacts on patients and carers. Semi-structured interviews were conducted with 15 patients and carers/parents in the UK, representing a range of rare conditions (including undiagnosed conditions). Transcripts were analysed thematically in an iterative process.
RESULTS
Participants described a range of experiences and views in relation to care coordination. Reports of uncoordinated care emerged: appointments were uncoordinated, communication between key stakeholders was ineffective, patients and carers were required to coordinate their own care, and care was not coordinated to meet the changing needs of patients in different scenarios. As a result, participants experienced an additional burden and barriers/delays to accessing care. The impacts described by patients and carers, either attributed to or exacerbated by uncoordinated care, included: impact on physical health (including fatigue), financial impact (including loss of earnings and travel costs), and psychosocial impact (including disruption to school, work and emotional burden). Overall data highlight the importance of flexible care, which meets individual needs throughout patients'/carers' journeys. Specifically, study participants suggested that the impacts may be addressed by: having support from a professional to coordinate care, changing the approach of clinics and appointments (where they take place, which professionals/services are available and how they are scheduled), and improving communication through the use of technology, care plans, accessible points of contact and multi-disciplinary team working.
CONCLUSION
This study provides further evidence of impacts of uncoordinated care; these may be complex and influenced by a number of factors. Approaches to coordination which improve access to care and lessen the time and burden placed on patients and carers may be particularly beneficial. Findings should influence future service developments (and the evaluation of such developments). This will be achieved, in the first instance, by informing the CONCORD Study in the UK.

Identifiants

pubmed: 33568181
doi: 10.1186/s13023-020-01664-6
pii: 10.1186/s13023-020-01664-6
pmc: PMC7874609
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

76

Subventions

Organisme : Department of Health
ID : 16/116/82
Pays : United Kingdom

Références

Genet Test Mol Biomarkers. 2010 Dec;14(6):807-15
pubmed: 20939735
Eur J Health Econ. 2015 Mar;16(2):113-8
pubmed: 25355295
Int J Integr Care. 2020 Jun 25;20(2):14
pubmed: 32607101
Disabil Health J. 2015 Oct;8(4):475-91
pubmed: 25959710
Orphanet J Rare Dis. 2017 Mar 31;12(1):63
pubmed: 28359278
Child Care Health Dev. 2019 Jan;45(1):96-103
pubmed: 30370696
Adv Exp Med Biol. 2010;686:223-50
pubmed: 20824449
Adm Policy Ment Health. 2015 Sep;42(5):533-44
pubmed: 24193818
Mol Genet Genomic Med. 2017 Nov;5(6):758-773
pubmed: 29178638
Addiction. 2016 Jun;111(6):1096-106
pubmed: 26806155
Orphanet J Rare Dis. 2015 Nov 24;10:149
pubmed: 26603037

Auteurs

Amy Simpson (A)

Genetic Alliance UK, Third Floor, 86-90 Paul Street, London, EC2A 4NE, UK. amy.simpson@geneticalliance.org.uk.

Lara Bloom (L)

The Ehlers-Danlos Society, Office 7, 35-37 Ludgate Hill, London, EC4M 7JN, UK.

Naomi J Fulop (NJ)

Department of Applied Health Research, University College London, London, UK.

Emma Hudson (E)

Department of Public Health and Primary Care, Institute of Public Health, University of Cambridge, Forvie Site, Robinson Way, Cambridge, UK.

Kerry Leeson-Beevers (K)

Alstrom Syndrome UK, 4 St Kitts Close, Torquay, TQ2 7GD, Devon, UK.

Stephen Morris (S)

Department of Public Health and Primary Care, Institute of Public Health, University of Cambridge, Forvie Site, Robinson Way, Cambridge, UK.

Angus I G Ramsay (AIG)

Department of Applied Health Research, University College London, London, UK.

Alastair G Sutcliffe (AG)

UCL and Great Ormond Street Institute of Child Health, London, UK.

Holly Walton (H)

Department of Applied Health Research, University College London, London, UK.

Amy Hunter (A)

Genetic Alliance UK, Third Floor, 86-90 Paul Street, London, EC2A 4NE, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH